Author

Rebecca Lefavor

Observed names: R. Lefavor, R.C. Lefavor, Rebecca C. Lefavor

Observed institutions: Mayo Clinic, Mayo Clinic in Florida

OpenAlex ID: A5028128191

Characterization and cost–benefit analysis of automated bioreactor‐expanded mesenchymal stem cells for clinical applications

2018 · Athena L. Russell, Rebecca C. Lefavor, et al. · Transfusion · 66

Modifiers of mesenchymal stem cell quantity and quality

2018 · Athena L. Russell, Rebecca Lefavor, et al. · Transfusion · 65

Feasibility, potency, and safety of growing human mesenchymal stem cells in space for clinical application

2020 · Peng Huang, Athena L. Russell, et al. · npj Microgravity · 61

Effect of hypoxia and xeno-free medium formulations on the mesenchymal stem cell secretome

2017 · A.L. Russell, R. Lefavor, et al. · Cytotherapy · 2

The Effect of Various Stimulants on Cytokine Secretion Profiles in Freshly Isolated Peripheral Blood Mononuclear Cells (PBMC)

2022 · Rebecca Lefavor, Emer Clarke · The Journal of Immunology

Short Term Safety and Tolerance of Mesenchymal Stem Cells (MSC) Infusion as Cell Therapy for Patients Experiencing Treatment-Refractory Moderate Chronic Lung Allograft Dysfunction (CLAD)

2016 · C.A. Keller, A.L. Russell, et al. · The Journal of Heart and Lung Transplantation

Biological Effects of Mesenchymal Stem Cell (MSC) Therapy in Patients with Chronic Lung Allograft Dysfunction (CLAD)

2016 · A.Z. Zubair, A.L. Russell, et al. · The Journal of Heart and Lung Transplantation

Works count: 7

Citation count: 194

H-index: 3

I10-index: 3